메뉴 건너뛰기




Volumn 17, Issue 2, 2011, Pages 222-228

Decreasing the adverse effects of cancer therapy: National cancer institute guidance for the clinical development of radiation injury mitigators

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); HUMAN; NATIONAL HEALTH ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; REVIEW; STUDY DESIGN; TREATMENT OUTCOME;

EID: 79251515199     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1402     Document Type: Review
Times cited : (28)

References (52)
  • 1
    • 0034305965 scopus 로고    scopus 로고
    • Phase III randomized trial of amifostine as a radioprotector in head and neck cancer
    • Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-45.
    • (2000) J Clin Oncol , vol.18 , pp. 3339-3345
    • Brizel, D.M.1    Wasserman, T.H.2    Henke, M.3    Strnad, V.4    Rudat, V.5    Monnier, A.6
  • 2
    • 78650630193 scopus 로고    scopus 로고
    • Prevention and treatment of radiation injuries - The role of the renin-angiotensin system
    • Rubin P, Constine LS, Mark LP, Okunieff P, editors. Heidelberg: Springer-Verlag
    • Cohen EP, Joines MM, Moulder JE. Prevention and treatment of radiation injuries - The role of the renin-angiotensin system. In: Rubin P, Constine LS, Mark LP, Okunieff P, editors. Late effects of cancer treatment on normal tissues. Heidelberg: Springer-Verlag; 2008. p. 69-76.
    • (2008) Late Effects of Cancer Treatment on Normal Tissues , pp. 69-76
    • Cohen, E.P.1    Joines, M.M.2    Moulder, J.E.3
  • 5
    • 44849121666 scopus 로고    scopus 로고
    • Medical countermeasures for radiation combined injury: Radiation with burn, blast, trauma and/or sepsis
    • report of an NIAID Workshop, March 26-27, 2007
    • DiCarlo AL, Hatchett RJ, Kaminski JM, Ledney GD, Pellmar TC, Okunieff P, et al. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007. Radiat Res 2008;169:712-21.
    • (2008) Radiat Res , vol.169 , pp. 712-721
    • DiCarlo, A.L.1    Hatchett, R.J.2    Kaminski, J.M.3    Ledney, G.D.4    Pellmar, T.C.5    Okunieff, P.6
  • 6
    • 33947512453 scopus 로고    scopus 로고
    • Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury
    • Moulder JE, Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol 2007;17:141-8.
    • (2007) Semin Radiat Oncol , vol.17 , pp. 141-148
    • Moulder, J.E.1    Cohen, E.P.2
  • 7
    • 58149328417 scopus 로고    scopus 로고
    • The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment
    • Robbins ME, Payne V, Tommasi E, Diz DI, Hsu FC, Brown WR, et al. The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys 2009;73:499-505.
    • (2009) Int J Radiat Oncol Biol Phys , vol.73 , pp. 499-505
    • Robbins, M.E.1    Payne, V.2    Tommasi, E.3    Diz, D.I.4    Hsu, F.C.5    Brown, W.R.6
  • 8
    • 79251515940 scopus 로고    scopus 로고
    • Total body irradiation-induced increase in risk factors for cardiovascular disease are mitigated by post irradiation treatment with losartan and curcumin
    • Lawrence (KS): Radiation Research Society
    • Baker JE, Fish B, Moulder JE. Total body irradiation-induced increase in risk factors for cardiovascular disease are mitigated by post irradiation treatment with losartan and curcumin. Proceedings of the 55th Annual Meeting of the Radiation Research Society ; 2009 Oct 4-7; Savannah (GA). Lawrence (KS): Radiation Research Society; 2010;143.
    • (2010) Proceedings of the 55th Annual Meeting of the Radiation Research Society; 2009 Oct 4-7; Savannah (GA) , pp. 143
    • Baker, J.E.1    Fish, B.2    Moulder, J.E.3
  • 9
    • 42949109332 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice
    • Brown SL, Kolozsvary A, Liu J, Ryu S, Kim JH. Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice. Radiat Res 2008;169:474-8.
    • (2008) Radiat Res , vol.169 , pp. 474-478
    • Brown, S.L.1    Kolozsvary, A.2    Liu, J.3    Ryu, S.4    Kim, J.H.5
  • 10
    • 34547429997 scopus 로고    scopus 로고
    • Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism
    • Wang J, Boerma M, Fu Q, Kulkarni A, Fink LM, Hauer-Jensen M. Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism. Int J Radiat Oncol Biol Phys 2007;68:1483-90.
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , pp. 1483-1490
    • Wang, J.1    Boerma, M.2    Fu, Q.3    Kulkarni, A.4    Fink, L.M.5    Hauer-Jensen, M.6
  • 11
    • 9244246263 scopus 로고    scopus 로고
    • Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries
    • Report of an NCI Workshop, December 3-4, 2003
    • Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res 2004;162:711-28.
    • (2004) Radiat Res , vol.162 , pp. 711-728
    • Stone, H.B.1    Moulder, J.E.2    Coleman, C.N.3    Ang, K.K.4    Anscher, M.S.5    Barcellos-Hoff, M.H.6
  • 12
    • 77953452311 scopus 로고    scopus 로고
    • Advances and perspectives in the molecular diagnosis of head and neck cancer
    • Mydlarz WK, Hennessey PT, Califano JA. Advances and perspectives in the molecular diagnosis of head and neck cancer. Expert Opin Med Diagn 2010;4:53-65.
    • (2010) Expert Opin Med Diagn , vol.4 , pp. 53-65
    • Mydlarz, W.K.1    Hennessey, P.T.2    Califano, J.A.3
  • 13
    • 23844559204 scopus 로고    scopus 로고
    • The scientific basis of radiotherapy
    • Tannock I, Hill RP, Bristow RG, Harrington L, editors. 4th ed. New York: McGraw-Hill Medical Publishing Company
    • Hill RP, Brisotw RG. The scientific basis of radiotherapy. In: Tannock I, Hill RP, Bristow RG, Harrington L, editors. The basic science of oncology. 4th ed. New York: McGraw-Hill Medical Publishing Company; 2005. p.289-323.
    • (2005) The Basic Science of Oncology , pp. 289-323
    • Hill, R.P.1    Brisotw, R.G.2
  • 14
    • 0036283219 scopus 로고    scopus 로고
    • The radiotherapeutic injury-a complex 'wound'
    • Denham JW, Hauer-Jensen M. The radiotherapeutic injury-a complex 'wound'. Radiother Oncol 2002;63:129-45.
    • (2002) Radiother Oncol , vol.63 , pp. 129-145
    • Denham, J.W.1    Hauer-Jensen, M.2
  • 15
    • 22144444484 scopus 로고    scopus 로고
    • Molecular markers predicting radiotherapy response: Report and recommendations from an International Atomic Energy Agency technical meeting
    • West CM, McKay MJ, Holscher T, Baumann M, Stratford IJ, Bristow RG, et al. Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys 2005;62:1264-73.
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , pp. 1264-1273
    • West, C.M.1    McKay, M.J.2    Holscher, T.3    Baumann, M.4    Stratford, I.J.5    Bristow, R.G.6
  • 16
    • 74549176997 scopus 로고    scopus 로고
    • Establishment of a radiogenomics consortium
    • West C, Rosenstein BS. Establishment of a radiogenomics consortium. Radiother Oncol 2010;94:117-8.
    • (2010) Radiother Oncol , vol.94 , pp. 117-118
    • West, C.1    Rosenstein, B.S.2
  • 17
    • 0034320191 scopus 로고    scopus 로고
    • Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice
    • Zheng H, Wang J, Koteliansky VE, Gotwals PJ, Hauer-Jensen M. Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice. Gastroenterology 2000;119:1286-96.
    • (2000) Gastroenterology , vol.119 , pp. 1286-1296
    • Zheng, H.1    Wang, J.2    Koteliansky, V.E.3    Gotwals, P.J.4    Hauer-Jensen, M.5
  • 18
    • 34848891816 scopus 로고    scopus 로고
    • Targeting transforming growth factor-beta signaling
    • DOI 10.1097/CCO.0b013e3282f0ad0e, PII 0000162220071100000007
    • Pennison M, Pasche B. Targeting transforming growth factor-beta signaling. Curr Opin Oncol 2007;19:579-85. (Pubitemid 47508864)
    • (2007) Current Opinion in Oncology , vol.19 , Issue.6 , pp. 579-585
    • Pennison, M.1    Pasche, B.2
  • 19
    • 0141653957 scopus 로고    scopus 로고
    • Effects of radiation on normal tissue: Consequences and mechanisms
    • Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529-36.
    • (2003) Lancet Oncol , vol.4 , pp. 529-536
    • Stone, H.B.1    Coleman, C.N.2    Anscher, M.S.3    McBride, W.H.4
  • 20
    • 5044223266 scopus 로고    scopus 로고
    • Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways
    • viii
    • Wachsberger P, Burd R, Dicker AP. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways. Hematol Oncol Clin North Am 2004;18:1039-57[viii.].
    • (2004) Hematol Oncol Clin North Am , vol.18 , pp. 1039-1057
    • Wachsberger, P.1    Burd, R.2    Dicker, A.P.3
  • 21
    • 51349098155 scopus 로고    scopus 로고
    • Cytokines as a key component of cancer-related inflammation
    • Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine 2008;43:374-9.
    • (2008) Cytokine , vol.43 , pp. 374-379
    • Germano, G.1    Allavena, P.2    Mantovani, A.3
  • 22
    • 35548987432 scopus 로고    scopus 로고
    • Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor
    • DOI 10.1667/RR0707.1
    • Kohl RR, Kolozsvary A, Brown SL, Zhu G, Kim JH. Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor. Radiat Res 2007;168:440-5. (Pubitemid 351303172)
    • (2007) Radiation Research , vol.168 , Issue.4 , pp. 440-445
    • Kohl, R.R.1    Kolozsvary, A.2    Brown, S.L.3    Zhu, G.4    Kim, J.H.5
  • 23
    • 0042074154 scopus 로고    scopus 로고
    • Celecoxib reduces skin damage after radiation: Selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor
    • Liang L, Hu D, Liu W, Williams JP, Okunieff P, Ding I. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am J Clin Oncol 2003;26:S114-21.
    • (2003) Am J Clin Oncol , vol.26
    • Liang, L.1    Hu, D.2    Liu, W.3    Williams, J.P.4    Okunieff, P.5    Ding, I.6
  • 24
    • 3042763035 scopus 로고    scopus 로고
    • Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model
    • Williams JP, Hernady E, Johnston CJ, Reed CM, Fenton B, Okunieff P, et al. Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiat Res 2004;161:560-7.
    • (2004) Radiat Res , vol.161 , pp. 560-567
    • Williams, J.P.1    Hernady, E.2    Johnston, C.J.3    Reed, C.M.4    Fenton, B.5    Okunieff, P.6
  • 25
    • 77955881529 scopus 로고    scopus 로고
    • Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: Results from CaPSURE
    • Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int 2010;106:627-32.
    • (2010) BJU Int , vol.106 , pp. 627-632
    • Katz, M.S.1    Carroll, P.R.2    Cowan, J.E.3    Chan, J.M.4    D'Amico, A.V.5
  • 28
    • 33947194301 scopus 로고    scopus 로고
    • Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: Importance of ramipril dose and treatment time
    • DOI 10.1007/s11060-006-9256-4
    • Ryu S, Kolozsvary A, Jenrow KA, Brown SL, Kim JH. Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time. J Neurooncol 2007;82:119-24. (Pubitemid 46431853)
    • (2007) Journal of Neuro-Oncology , vol.82 , Issue.2 , pp. 119-124
    • Ryu, S.1    Kolozsvary, A.2    Jenrow, K.A.3    Brown, S.L.4    Kim, J.H.5
  • 30
    • 33645689430 scopus 로고    scopus 로고
    • Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands
    • Lombaert IM, Wierenga PK, Kok T, Kampinga HH, deHaan G, Coppes RP. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res 2006;12:1804-12.
    • (2006) Clin Cancer Res , vol.12 , pp. 1804-1812
    • Lombaert, I.M.1    Wierenga, P.K.2    Kok, T.3    Kampinga, H.H.4    DeHaan, G.5    Coppes, R.P.6
  • 32
    • 75749114436 scopus 로고    scopus 로고
    • p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis
    • Kirsch DG, Santiago PM, di Tomaso E, Sullivan JM, Hou WS, Dayton T, et al. p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science 2010;327:593-6.
    • (2010) Science , vol.327 , pp. 593-596
    • Kirsch, D.G.1    Santiago, P.M.2    Di Tomaso, E.3    Sullivan, J.M.4    Hou, W.S.5    Dayton, T.6
  • 33
    • 64549122013 scopus 로고    scopus 로고
    • Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources
    • Williston Park
    • Vikram B, Coleman CN, Deye JA. Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources. Oncology 2009;23:279-83[Williston Park].
    • (2009) Oncology , vol.23 , pp. 279-283
    • Vikram, B.1    Coleman, C.N.2    Deye, J.A.3
  • 35
    • 70349770964 scopus 로고    scopus 로고
    • Radiotherapy: IMRT reduces xerostomia and potentially improves QoL
    • Eisbruch A. Radiotherapy: IMRT reduces xerostomia and potentially improves QoL. Nat Rev Clin Oncol 2009;6:567-8.
    • (2009) Nat Rev Clin Oncol , vol.6 , pp. 567-568
    • Eisbruch, A.1
  • 36
    • 76049120553 scopus 로고    scopus 로고
    • Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy
    • Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010;76:775-81.
    • (2010) Int J Radiat Oncol Biol Phys , vol.76 , pp. 775-781
    • Liao, Z.X.1    Komaki, R.R.2    Thames Jr., H.D.3    Liu, H.H.4    Tucker, S.L.5    Mohan, R.6
  • 38
    • 77949407113 scopus 로고    scopus 로고
    • The missing voice of patients in drug-safety reporting
    • Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010;362:865-9.
    • (2010) N Engl J Med , vol.362 , pp. 865-869
    • Basch, E.1
  • 39
    • 70350238222 scopus 로고    scopus 로고
    • DCTD, NCI, NIH, DHHS, Available from updated 15 April 2010; accessed 4 June 2010
    • Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v4.0, DCTD, NCI, NIH, DHHS. Available from: http://ctep.cancer. gov/protocolDevelopment/electronic-applications/docs/ctcae-index.pdf#search= "common terminology". [updated 15 April 2010; accessed 4 June 2010.]
    • Common Terminology Criteria for Adverse Events V4.0
  • 40
    • 36849093844 scopus 로고    scopus 로고
    • Patient-reported outcomes and the evolution of adverse event reporting in oncology
    • Trotti A, Colevas AD, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 2007;25:5121-7.
    • (2007) J Clin Oncol , vol.25 , pp. 5121-5127
    • Trotti, A.1    Colevas, A.D.2    Setser, A.3    Basch, E.4
  • 41
    • 33746261692 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research Washington: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research
    • U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Washington: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2009.
    • (2009) Guidance for Industry Patient-reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
  • 42
    • 77951626978 scopus 로고    scopus 로고
    • Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: Randomized RTOG trial 0315
    • Zachariah B, Gwede CK, James J, Ajani J, Chin LJ, Donath D, et al. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315. J Natl Cancer Inst 2010;102:547-56.
    • (2010) J Natl Cancer Inst , vol.102 , pp. 547-556
    • Zachariah, B.1    Gwede, C.K.2    James, J.3    Ajani, J.4    Chin, L.J.5    Donath, D.6
  • 44
    • 20244383481 scopus 로고    scopus 로고
    • Randomized trial of amifostine in locally advanced non-smallcell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation therapy oncology group trial 98-01
    • Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, et al. Randomized trial of amifostine in locally advanced non-smallcell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 2005;23:2145-54.
    • (2005) J Clin Oncol , vol.23 , pp. 2145-2154
    • Movsas, B.1    Scott, C.2    Langer, C.3    Werner-Wasik, M.4    Nicolaou, N.5    Komaki, R.6
  • 45
    • 0038071449 scopus 로고    scopus 로고
    • Does amifostine have a role in chemoradiation treatment?
    • Brizel DM, Overgaard J. Does amifostine have a role in chemoradiation treatment?Lancet Oncol 2003;4:378-81.
    • (2003) Lancet Oncol , vol.4 , pp. 378-381
    • Brizel, D.M.1    Overgaard, J.2
  • 46
    • 56349137675 scopus 로고    scopus 로고
    • Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: An analysis of RTOG 9801
    • Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, et al. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 2008;72:1378-84.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 1378-1384
    • Sarna, L.1    Swann, S.2    Langer, C.3    Werner-Wasik, M.4    Nicolaou, N.5    Komaki, R.6
  • 47
    • 33750305266 scopus 로고    scopus 로고
    • Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study
    • Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 2006;7:903-9.
    • (2006) Lancet Oncol , vol.7 , pp. 903-909
    • Basch, E.1    Iasonos, A.2    McDonough, T.3    Barz, A.4    Culkin, A.5    Kris, M.G.6
  • 48
    • 33645959171 scopus 로고    scopus 로고
    • The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires
    • Jensen K, Bonde JA, Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 2006;78:298-305.
    • (2006) Radiother Oncol , vol.78 , pp. 298-305
    • Jensen, K.1    Bonde, J.A.2    Grau, C.3
  • 49
  • 51
    • 53249111808 scopus 로고    scopus 로고
    • The Translational Research Working Group developmental pathways: Introduction and overview
    • Hawk ET, Matrisian LM, Nelson WG, Dorfman GS, Stevens L, Kwok J, et al. The Translational Research Working Group developmental pathways: introduction and overview. Clin Cancer Res 2008;14:5664-71.
    • (2008) Clin Cancer Res , vol.14 , pp. 5664-5671
    • Hawk, E.T.1    Matrisian, L.M.2    Nelson, W.G.3    Dorfman, G.S.4    Stevens, L.5    Kwok, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.